Cargando…
The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram
Background: Acute heart failure (AHF) is a severe clinical syndrome characterized as rapid onset or worsening of symptoms of chronic heart failure (CHF). Risk stratification for patients with AHF in the intensive care unit (ICU) may help clinicians to predict the 28-day mortality risk in this subpop...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678052/ https://www.ncbi.nlm.nih.gov/pubmed/34926602 http://dx.doi.org/10.3389/fcvm.2021.741351 |
_version_ | 1784616268837421056 |
---|---|
author | Wei, Xiaoyuan Min, Yu Yu, Jiangchuan Wang, Qianli Wang, Han Li, Shuang Su, Li |
author_facet | Wei, Xiaoyuan Min, Yu Yu, Jiangchuan Wang, Qianli Wang, Han Li, Shuang Su, Li |
author_sort | Wei, Xiaoyuan |
collection | PubMed |
description | Background: Acute heart failure (AHF) is a severe clinical syndrome characterized as rapid onset or worsening of symptoms of chronic heart failure (CHF). Risk stratification for patients with AHF in the intensive care unit (ICU) may help clinicians to predict the 28-day mortality risk in this subpopulation and further raise the quality of care. Methods: We retrospectively reviewed and analyzed the demographic characteristics and serological indicators of patients with AHF in the Medical Information Mart for Intensive Care III (MIMIC III) (version 1.4) between June 2001 and October 2012 and our medical center between January 2019 and April 2021. The chi-squared test and the Fisher's exact test were used for comparison of qualitative variables among the AHF death group and non-death group. The clinical variables were selected by using the least absolute shrinkage and selection operator (LASSO) regression. A clinical nomogram for predicting the 28-day mortality was constructed based on the multivariate Cox proportional hazard regression analysis and further validated by the internal and external cohorts. Results: Age > 65 years [hazard ratio (HR) = 2.47], the high Sequential Organ Failure Assessment (SOFA) score (≥3 and ≤8, HR = 2.21; ≥9 and ≤20, HR = 3.29), lactic acid (Lac) (>2 mmol/l, HR = 1.40), bicarbonate ([Formula: see text]) (>28 mmol/l, HR = 1.59), blood urea nitrogen (BUN) (>21 mg/dl, HR = 1.75), albumin (<3.5 g/dl, HR = 2.02), troponin T (TnT) (>0.04 ng/ml, HR = 4.02), and creatine kinase-MB (CK-MB) (>5 ng/ml, HR = 1.64) were the independent risk factors for predicting 28-day mortality of intensive care patients with AHF (p < 0.05). The novel nomogram was developed and validated with a promising C-index of 0.814 (95% CI: 0.754–0.882), 0.820 (95% CI: 0.721–0.897), and 0.828 (95% CI: 0.743–0.917), respectively. Conclusion: This study provides a new insight in early predicting the risk of 28-day mortality in intensive care patients with AHF. The age, the SOFA score, and serum TnT level are the leading three predictors in evaluating the short-term outcome of intensive care patients with AHF. Based on the nomogram, clinicians could better stratify patients with AHF at high risk and make adequate treatment plans. |
format | Online Article Text |
id | pubmed-8678052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86780522021-12-18 The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram Wei, Xiaoyuan Min, Yu Yu, Jiangchuan Wang, Qianli Wang, Han Li, Shuang Su, Li Front Cardiovasc Med Cardiovascular Medicine Background: Acute heart failure (AHF) is a severe clinical syndrome characterized as rapid onset or worsening of symptoms of chronic heart failure (CHF). Risk stratification for patients with AHF in the intensive care unit (ICU) may help clinicians to predict the 28-day mortality risk in this subpopulation and further raise the quality of care. Methods: We retrospectively reviewed and analyzed the demographic characteristics and serological indicators of patients with AHF in the Medical Information Mart for Intensive Care III (MIMIC III) (version 1.4) between June 2001 and October 2012 and our medical center between January 2019 and April 2021. The chi-squared test and the Fisher's exact test were used for comparison of qualitative variables among the AHF death group and non-death group. The clinical variables were selected by using the least absolute shrinkage and selection operator (LASSO) regression. A clinical nomogram for predicting the 28-day mortality was constructed based on the multivariate Cox proportional hazard regression analysis and further validated by the internal and external cohorts. Results: Age > 65 years [hazard ratio (HR) = 2.47], the high Sequential Organ Failure Assessment (SOFA) score (≥3 and ≤8, HR = 2.21; ≥9 and ≤20, HR = 3.29), lactic acid (Lac) (>2 mmol/l, HR = 1.40), bicarbonate ([Formula: see text]) (>28 mmol/l, HR = 1.59), blood urea nitrogen (BUN) (>21 mg/dl, HR = 1.75), albumin (<3.5 g/dl, HR = 2.02), troponin T (TnT) (>0.04 ng/ml, HR = 4.02), and creatine kinase-MB (CK-MB) (>5 ng/ml, HR = 1.64) were the independent risk factors for predicting 28-day mortality of intensive care patients with AHF (p < 0.05). The novel nomogram was developed and validated with a promising C-index of 0.814 (95% CI: 0.754–0.882), 0.820 (95% CI: 0.721–0.897), and 0.828 (95% CI: 0.743–0.917), respectively. Conclusion: This study provides a new insight in early predicting the risk of 28-day mortality in intensive care patients with AHF. The age, the SOFA score, and serum TnT level are the leading three predictors in evaluating the short-term outcome of intensive care patients with AHF. Based on the nomogram, clinicians could better stratify patients with AHF at high risk and make adequate treatment plans. Frontiers Media S.A. 2021-12-03 /pmc/articles/PMC8678052/ /pubmed/34926602 http://dx.doi.org/10.3389/fcvm.2021.741351 Text en Copyright © 2021 Wei, Min, Yu, Wang, Wang, Li and Su. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Wei, Xiaoyuan Min, Yu Yu, Jiangchuan Wang, Qianli Wang, Han Li, Shuang Su, Li The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram |
title | The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram |
title_full | The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram |
title_fullStr | The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram |
title_full_unstemmed | The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram |
title_short | The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram |
title_sort | value of admission serological indicators for predicting 28-day mortality in intensive care patients with acute heart failure: construction and validation of a nomogram |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678052/ https://www.ncbi.nlm.nih.gov/pubmed/34926602 http://dx.doi.org/10.3389/fcvm.2021.741351 |
work_keys_str_mv | AT weixiaoyuan thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT minyu thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT yujiangchuan thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT wangqianli thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT wanghan thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT lishuang thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT suli thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT weixiaoyuan valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT minyu valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT yujiangchuan valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT wangqianli valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT wanghan valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT lishuang valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram AT suli valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram |